Study Results Reveal alli(R) Patient Satisfaction Linked to Weight Loss Achieved; Not Treatme...(ity behavior environmentand genetics. Mu...),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Study Results Reveal alli(R) Patient Satisfaction Linked to Weight Loss Achieved; Not Treatment Effects
Date:10/22/2007
ity, behavior, environment, and genetics. Multiple studies have shown that a modest reduction in weight improves health outcomes significantly in overweight or obese patients.
About alli(R) Weight Loss Aid
alli (orlistat 60mg), the only FDA-approved weight-loss product available to overweight adults without a prescription, combines a clinically-proven product with a comprehensive individualized action plan. The alli program encourages modest, gradual weight loss, known by experts as the best way to lose weight. alli is to be taken three times a day with meals containing fat and has been available in pharmacies and mass retailers nationwide since June 15, 2007.
About GlaxoSmithKline Consumer Healthcare
GSK Consumer Healthcare is one of the world's largest over-the-counter consumer healthcare products companies. Its more than 30 well-known brands include the leading smoking cessation products, Nicorette(R), NicoDerm(R) CQ and Commit(R) as well as many medicine cabinet staples, including Abreva(R), Aquafresh(R), Sensodyne(R), Tums(R) and Breathe Right(R).
About GlaxoSmithKline
GlaxoSmithKline -- one of the world's leading research-based pharmaceutical and healthcare companies -- is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information visit: http://www.gsk.com.
'/>"/>
| SOURCE GlaxoSmithKline Consumer Healthcare Copyright©2007 PR Newswire. All rights reserved |
Related medicine technology :
1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:11/25/2009)...TheNetherlandsandJOHANNESBURG,November25/PRNewswir...sDiscoveryannouncedtoday,thattheyhavesignedacollab...ices. , Pyxis,sworldclasscomputationalchemist...ba,sservicedivisiontoprovidemedicinaland,synthetic...internationalclientnetwork.iThembaPharmaceuticalsa...
(Date:11/24/2009)...,Calif.,Nov.24/PRNewswire-FirstCall/--Endologix,In...tmentsforaorticdisorders,announcedtodaythatithasfi...patentinfringementlawsuitbroughtagainstitinOctober...istrictCourtinIndianapolis,Indiana. ,, Endologi...edStatesPatentandTrademarkOffice(USPTO)conductspro...
(Date:11/24/2009)...C,Md.,Nov.24/PRNewswire/--Inadditiontofamily,frien...ladelphiajurorstoherThanksgivinggratitudelist. ,...nkfultothem,"shesaidofMonday,sverdictstotaling$103... Wisneskiisamong12,000womennationwidewhohavesuedWy...apydrugsPremarinandPrempro.Wisneskiandtheothervict...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Maryland Woman Thankful for Wyeth Verdicts 2Swine Flu Shots Safe for People With Weak Immune Systems 3A Experts 57649 1Swine Flu Shots Safe for People With Weak Immune Systems 3A Experts 57649 2Swine Flu Shots Safe for People With Weak Immune Systems 3A Experts 57649 3Hot microbes cause groundwater cleanup rethink 9979 1Hot microbes cause groundwater cleanup rethink 9979 2Researchers prolong the half life of biopharmaceutical proteins 9974 1Researchers prolong the half life of biopharmaceutical proteins 9974 2...ng Flu and CDC Partner to Declare November 27 "Nat...20,000 Children Under Age Five Are Hospitalized Ea...s Fighting Flu, Inc.,(FFF), together with the U.S....and other health organizations are reminding paren... with and care for them, vaccinated,against influe...
...if. and DEERFIELD, Ill., Nov. 27 ,Computer Science...ynPort,Vaccine Company LLC (DVC), a CSC company, i...: BAX ), has received a $201.2 million contract,m... Human Services (HHS),for the development of Baxte...candidate vaccines. CSC reported the full potentia...
Other Medicine Technology:Health Experts and Families Encourage Annual Childhood Flu Vaccination to Reduce Flu-Related Illnesses and Deaths in Children 2Health Experts and Families Encourage Annual Childhood Flu Vaccination to Reduce Flu-Related Illnesses and Deaths in Children 3Health Experts and Families Encourage Annual Childhood Flu Vaccination to Reduce Flu-Related Illnesses and Deaths in Children 4U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSC's DVC and Baxter 2U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSC's DVC and Baxter 3(Date:11/26/2009)...n Communications announces a highly effective and ...s struggling to make an economic recovery. , ...lu fears is the type of challenge that could send ...ing to Dr. David Benton, business growth expert an...tem – The Rfactor Intensive . “Fear...
(Date:11/25/2009)...RNewswire/--TheBartleHallConventionCenterwilltempo...-10,whenKansasCityhoststhelatestinaseriesofmassive...iceventhasthepotentialtobethebiggestoneyet,because...weekdaysinsteadofoveraweekend,"SheriWood,executive...toftheNationalAssociationofFreeClinics(NAFC). ,...
(Date:11/25/2009)...re/-SentinelleMedicalInc.,aleadingmanufacturerofbr...esasuiteofnewleadingedgeclinicalapplicationsonitsA...RadiologicalSocietyofNorthAmerica(RSNA)annualmeeti...applicationsleveragetheuniquehighqualityimagesgene...pportmultipleimagingmodalitiesformulti-parametrica...
(Date:11/25/2009)...swire-USNewswire/--TheBlackAIDSInstituterecentlyhe...ershipfor2010. ,, ThenewBoardMembersareahighlyd...law,finance,governmenthealthprograms,editorial,and...erangeofpersonalbackgroundsincludingbothheterosexu...es,andrepresentingmultipleagegroups. ,, (Photo:...
(Date:11/25/2009)...ular cancer who were treated with cisplatin-based ...ng neurological side effects and Raynaud-like phen...rapy, according to a new study published online No...nstitute . , Marianne Brydy, M.D., of the Depart...n Bergen, Norway, and colleagues conducted a cross...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2[1] Pharmacist Injects Cure for Ailing Businesses [1] Kansas City Prepares for Largest Free Health Clinic[1] Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology[0] Black AIDS Institute Announces 2010 Board Election Results[1] News brief: Long-term testicular cancer survivors at high risk for neurological side effects
...c.,(Pink Sheets: MEDQ.PK) today announced that it ...Q for the first two quarters of 2007 and expects,f...e Commission (SEC) by,the middle of October 2007. ... time since the filing of its Form,10-Q for the th...
... lives of patients who have suffered a stroke and ...o a study published on bmj.com today. , Stroke ...and the leading cause of serious, long-term disabi...g, dressing and going to the toilet. We already k...
...as the elderly and people with physical or mental ...n assisted death are not supported by evidence, sa...ted death (both voluntary active euthanasia and ph...uicide was also legalised in Oregon in 1997, write...
... for a $100 million initiative to create an instit...lth problems in the developing world, such as HIV/...nced today during the annual meeting of the Clinto..., with the goal of establishing an institute that ...
...completion, SAN FRANCISCO, Sept. 28 Inspired fat...five-month 2,200-mile fundraising journey to,the G...n San Francisco,Calif., two weeks ahead of schedul...y 19 years. Among centers serving the development...
...on,Pharmaceuticals LLC, a clinical-stage drug deve...gs utilizing a novel mechanism of action,that enha... of a Phase I,safety trial of its lead drug candid... support the company,s overall growth,and advance ...
Other Medicine News:Health News:MedQuist Updates Status of Outstanding SEC Filings 2Health News:Vulnerable groups are not at higher risk of physician-assisted death 2Health News:Rice unveils $100 million initiative for world health technology 2Health News:Rice unveils $100 million initiative for world health technology 3Health News:Man Walking to California for Son Approaching Finish Line 2Health News:Diffusion Pharmaceuticals Announces Results of Phase I Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC) and Completion of a $4.5 Million Private Placement 2Health News:Diffusion Pharmaceuticals Announces Results of Phase I Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC) and Completion of a $4.5 Million Private Placement 3Health News:Diffusion Pharmaceuticals Announces Results of Phase I Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC) and Completion of a $4.5 Million Private Placement 4MedQuist Updates Status of Outstanding SEC FilingsOccupational therapy is an effective way of improving the daily life of stroke patientsVulnerable groups are not at higher risk of physician-assisted deathRice unveils $100 million initiative for world health technologyMan Walking to California for Son Approaching Finish LineDiffusion Pharmaceuticals Announces Results of Phase I Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC) and Completion of a $4.5 Million Private Placement
Avant E-Z Rack Premium Low Binding Microreach Pipet Tips
Finntip Wide 100-1000 L
Finntip 250 Universal Refill Pack
MBP 200G Genomic Tip
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |